No. Mounjaro contains tirzepatide, not insulin. Tirzepatide is a dual GIP and GLP 1 receptor agonist, so it works differently from insulin. Rather than replacing insulin directly, it helps your body release more of its own insulin when blood glucose levels are elevated. Insulin, on the other hand, is a hormone your body naturally produces, and injected insulin replaces or supplements the insulin your body needs.
For adults in the UK considering Mounjaro for type 2 diabetes or weight management, understanding this difference can make treatment options easier to discuss with your prescriber. Mounjaro is licensed in the UK for managing type 2 diabetes and for weight management in eligible adults. Insulin is primarily used to manage blood glucose in people with diabetes when insulin treatment is needed.
So, when people ask "is Mounjaro insulin?", there are two separate questions to consider: are they the same medicine, and can Mounjaro replace insulin? The answer to the first is no. The answer to the second depends on the individual and should only be decided with a prescriber. This guide explains how Mounjaro and insulin work differently, how they are used for type 2 diabetes, what clinical evidence shows, and why you should not change an existing insulin treatment without medical advice.
What Mounjaro Actually Contains
Mounjaro contains tirzepatide, a prescription only medicine that activates two hormone receptors called GIP and GLP 1. These pathways are involved in appetite, digestion and blood glucose regulation.
Tirzepatide is not insulin and does not replace insulin in the body. Instead, it can help the pancreas release insulin when blood glucose levels are elevated. It can also reduce glucagon release and slow gastric emptying, which can contribute to better blood glucose control and changes in appetite and fullness.
Because tirzepatide's effect on insulin release is glucose dependent, the risk of low blood glucose can be lower when it is used on its own than with insulin or some other diabetes medicines. However, the risk can increase when Mounjaro is used alongside insulin or medicines such as sulfonylureas, so your prescriber may need to review your treatment.
How the Mechanism Differs From Insulin in Managing Blood Sugar Levels
Insulin treatment works by providing insulin directly. This allows glucose to move from the bloodstream into cells where it can be used or stored. People with type 1 diabetes need insulin, while some people with type 2 diabetes may also need insulin when their body does not produce enough or when other treatments are no longer providing adequate blood glucose control.
Tirzepatide works differently. It activates GIP and GLP 1 receptors and can increase glucose dependent insulin release, reduce glucagon secretion and slow gastric emptying. It can also reduce appetite and increase feelings of fullness.
This means Mounjaro and insulin can both help improve blood glucose levels, but they do so through different mechanisms. Mounjaro's additional effects on appetite and body weight are also relevant when it is prescribed for weight management.
Mounjaro vs Insulin in Type 2 Diabetes
This is where the difference can become confusing, because both are injectable treatments that may be used by people with type 2 diabetes.
Mounjaro is licensed for the treatment of type 2 diabetes and may be prescribed when additional blood glucose control is needed. The choice of treatment depends on factors such as your current blood glucose levels, other medicines, health conditions and individual treatment needs.
Mounjaro is given once weekly. Insulin schedules vary depending on the type of insulin and the person's treatment plan. Some people may use a long acting insulin once daily, while others may need more frequent injections.
Mounjaro is therefore not simply a different form of insulin. It is a different type of medicine that can be used to help manage type 2 diabetes in appropriate patients. If you already use insulin, do not reduce, stop or replace it yourself. Your prescriber can assess whether Mounjaro is suitable and, if treatment is changed, explain how this should be done safely.
Several head to head clinical trials have directly compared tirzepatide with insulin in people with type 2 diabetes:
| Trial | Comparator | Duration | HbA1c change | Weight change | Hypoglycaemia |
|---|---|---|---|---|---|
| SURPASS-4 | Insulin glargine | 52 weeks | Tirzepatide 15mg: -2.58% vs glargine -1.44% | Tirzepatide: -11.7kg vs glargine: +1.9kg | Lower with tirzepatide |
| SURPASS-6 | Insulin lispro, a fast-acting insulin (added to basal insulin) | 52 weeks | Tirzepatide: -2.1% vs lispro: -1.1% | Tirzepatide: weight loss vs lispro: weight gain | Lower with tirzepatide |
In SURPASS 6, a phase 3 trial sponsored by Eli Lilly, tirzepatide produced a greater average reduction in HbA1c than insulin lispro when both were used alongside insulin glargine. Average HbA1c fell by 2.1 percentage points with tirzepatide compared with 1.1 percentage points with insulin lispro. Around 56% of participants receiving tirzepatide reached an HbA1c of 6.5% or lower. Clinically significant hypoglycaemia was also reported less often with tirzepatide than with insulin lispro in the trial. These are published trial results, but they do not mean Mounjaro is automatically better than insulin for everyone.
Insulin remains an important treatment for many people with type 2 diabetes and is essential for people with type 1 diabetes. Mounjaro is not licensed to treat type 1 diabetes.
Can Mounjaro Replace Insulin?
This is a decision for you and your diabetes healthcare team, not something to change on your own. Whether someone already using insulin can reduce or stop it after starting Mounjaro depends on their individual diabetes history, blood glucose control, other medicines and how they respond to treatment.
If Mounjaro is added alongside insulin, your prescriber may need to review your insulin dose and blood glucose monitoring. Changing or stopping insulin without medical advice can cause blood glucose levels to rise dangerously. If you currently use insulin and are considering Mounjaro, speak to the clinician managing your diabetes before making any changes to your treatment.
Mounjaro for Weight Loss and Weight Management vs Insulin's Role in Diabetes
Mounjaro also has a separate licensed use for weight management in eligible adults. For this purpose, it is prescribed alongside a reduced calorie diet and increased physical activity following a clinical assessment. Your prescriber may consider factors such as BMI, weight related health conditions and your wider medical history.
Insulin does not have a licensed use for weight management. Some insulin treatments can also be associated with weight gain, although the effect varies between individuals and treatment regimens.
Clinical trials of tirzepatide have shown substantial average weight loss over time, with higher doses generally associated with greater average reductions in body weight. These results are averages from clinical studies and should not be taken as a prediction of how much weight you will lose.
If your main goal is weight management rather than blood glucose control, your prescriber can assess whether Mounjaro is appropriate for you separately from any diabetes treatment you may already be using. You can find more information about prescription weight loss treatments and eligibility criteria.
Administration and Dosing Schedules Compared: Mounjaro vs Basal Insulin
Mounjaro is given once weekly as a subcutaneous injection using a pre filled pen. Insulin schedules vary depending on the type of insulin prescribed. Some people use a long acting insulin once daily, while others may need more than one injection each day, including around meals.
Both treatments are injections, so injection site reactions such as redness, soreness, swelling or itching can occur with either medicine. There is no single schedule that is right for everyone. Your prescriber will recommend a treatment plan based on your diabetes, other medicines and individual needs.
Side Effect and Safety Profiles Compared
Both Mounjaro and insulin can cause side effects, but the types of side effects are different.
With Mounjaro, the most commonly reported side effects tend to affect the digestive system. These can include nausea, reduced appetite, diarrhoea, constipation, vomiting and digestive discomfort, particularly when treatment is started or the dose is increased. More serious problems, such as pancreatitis, gallbladder problems or kidney injury related to dehydration, are less common but should be assessed by a healthcare professional if symptoms occur.
With insulin, one of the main risks is hypoglycaemia, or low blood sugar. This can happen when the insulin dose is higher than the body needs in relation to food intake, activity or other factors. The SURPASS trials found lower rates of hypoglycaemia with tirzepatide than with some insulin comparators, but this does not mean Mounjaro cannot cause low blood sugar, particularly when it is used with insulin or certain other diabetes medicines.
People with a personal or family history of medullary thyroid carcinoma should discuss this with their prescriber before starting Mounjaro. Your healthcare professional can explain which side effects to look out for and when you should seek medical advice.
Who Might Be Prescribed Mounjaro vs Insulin
The choice between Mounjaro, insulin and other diabetes medicines depends on your individual circumstances.
For Mounjaro, your prescriber may consider your diabetes control, overall health, current medicines and, where weight management is the treatment goal, your BMI and weight related health conditions. They will also consider which diabetes treatments you have already tried and how you have responded to them.
For insulin, the decision depends on factors such as the type of diabetes, current blood glucose levels, how much insulin your body produces and the type of insulin regimen that is appropriate for you. Some people with type 2 diabetes use insulin alongside other diabetes medicines.
For many people, diabetes treatment involves balancing blood glucose control with weight, lifestyle and other health goals. This is why it is usually more helpful to discuss your individual treatment options with your diabetes healthcare team rather than viewing Mounjaro and insulin as direct alternatives.
Accessing Mounjaro and Insulin Through a UK Pharmacy
EverydayMeds is a GPhC registered pharmacy that can supply Mounjaro following an online clinical assessment and prescription from a UK licensed prescriber. Mounjaro is licensed in the UK and is also approved for certain uses in the US.
Insulin is also a prescription only medicine and is generally managed through your GP or diabetes team because insulin treatment often requires ongoing blood glucose monitoring and dose adjustments.
If you are interested in Mounjaro treatment for weight management or type 2 diabetes, an online clinical assessment can help determine whether it is suitable for you.